RRoche Read More Roche pens $490m Astex breast cancer license deal2026-07-06 Roche has taken fresh steps to uphold its breast cancer legacy defined by Herceptin (trastuzumab) and Perjeta (pertuzumab),…
RRoche Read More Roche, Nurix in $2.3B BTK degrader alliance2026-06-08 Roche (OTCQX:RHHBY) entered an exclusive global licensing and collaboration agreement with Nurix Therapeutics…